Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [11C] DASB positron emission tomography study
Swen Hesse, Osama Sabri(Klinik und Poliklinik für Nuklearmedizin), Michael Rullmann(Klinik und Poliklinik für Nuklearmedizin), Ralf Regenthal(Leipzig University), Julia Luthardt(Leipzig University), Katrin Arélin(Max Planck Institute for Human Cognitive and Brain Sciences), G Reissig(Leipzig University), Donald Lobsien(Helios Klinikum Erfurt), Mohammed K. Hankir(Trinity College Dublin), Mandy Drabe(IFB Adiposity Diseases), Michael Stümvoll(University Hospital Leipzig), Mathias Faßhauer(Center for Clinical Research (United States)), Marianne Patt, Franziska Zientek(Leipzig University), Georg‐Alexander Becker(Leipzig University), Matthias Blüher(Helmholtz Centre for Environmental Research), Philipp Meyer(Leipzig University), Wiebke Fenske(University of Bonn), Karsten Winter(Leipzig University), Anke Bresch(Leipzig University), Christian Schinke(Leipzig University)
European Journal of Nuclear Medicine and Molecular Imaging
November 18, 2015
Cited by 27
Related Papers
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
|New England Journal of Medicine|2006|1.3k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Metabolically Healthy Obesity
|Endocrine Reviews|2020|995